NSRX 424B4 DEF-14A Report Aug. 14, 2025 | Alphaminr
Nasus Pharma Ltd

NSRX 424B4 Report ended Aug. 14, 2025

NASUS PHARMA LTD
CIK: 2029039
Filing Type: 424B4
Report Date: 2025-08-14
Download URL: https://www.sec.gov/Archives/edgar/data/2029039/000164117225023826/form424b4.htm
]]>
TABLE OF CONTENTS